| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $1.5M+4710.5% | $31K-55.8% | $71K+5375.1% | $1K |
| Cost of revenue | $209K | — | — | — |
| Gross profit | $1.3M+4044.1% | $31K | — | — |
| Research and development | $1.2M+31.4% | $897K+18.4% | $757K+380.3% | $158K |
| General and administrative | $2.9M-1.7% | $2.9M-27.9% | $4.1M+508.5% | $670K |
| Advertising and marketing | $26K-72.2% | $93K-51.9% | $193K+287.0% | $50K |
| Legal and professional | $687K+9.8% | $626K+34.6% | $465K+7.0% | $434K |
| Total operating expenses | $4.8M+5.0% | $4.6M-26.3% | $6.2M+370.8% | $1.3M |
| Loss from operations | -$3.5M+23.0% | -$4.5M+25.9% | -$6.1M-365.9% | -$1.3M |
| Interest expense | -$357K-383.3% | -$74K-71.2% | -$43K-29.4% | -$33K |
| Total other expense | -$357K-383.3% | -$74K-71.2% | -$43K-29.4% | -$33K |
| Net loss | -$3.8M+16.4% | -$4.6M+25.2% | -$6.1M-357.5% | -$1.3M |
| Common stock dividend | -$1.0M | — | — | — |
| Net loss available to common shareholders | -$3.8M+31.5% | -$5.6M+8.8% | -$6.1M | — |
| Basic | $38.6M+14.0% | $33.9M+18.7% | $28.5M+28.3% | $22.2M |
| Diluted | $38.6M+14.0% | $33.9M+18.7% | $28.5M+28.3% | $22.2M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.